James Investment Research’s BioSpecifics Technologies Corp. BSTC Stock Holding History

James Investment Research’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-6,460	Closed	-$341K	–	556
2020 Q3	$341K	Hold	6,460	–	–	0.03%	228
2020 Q2	$396K	Buy	6,460 +1,500	+30%	+$86.8K	0.04%	212
2020 Q1	$281K	Buy	+4,960	New	+$283K	0.03%	209

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

James Investment Research's BSTC Position: Q4 2020 in Review

James Investment Research sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 6,460 shares — an estimated $341K sold.

James Investment Research first reported a position in BSTC in Q1 2020 and held it in 3 quarters. The position peaked at $396K in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

James Investment Research reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
James Investment Research sold 6,460 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $341K.
James Investment Research first reported a position in BioSpecifics Technologies Corp. in Q1 2020 and held it in 3 quarters.
James Investment Research's BioSpecifics Technologies Corp. position peaked at $396K in Q2 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on James Investment Research's 13F filing for Q4 2020, filed 27 Jan 2021.